UNITAID Strategy 2013-2016

With this new Strategy 2013-2016, UNITAID enters what could be called the third stage of its
development.

UNITAID's mission has remained constant over the years. It increases access to treatment for HIV/
AIDS, TB and malaria for people in developing countries by leveraging price reductions of quality drugs and diagnostics, which currently are unaffordable for most developing countries, and to accelerate the pace at which they are made available.

The UNITAID Strategy 2013-2016 provides an excellent vision that will guide new investments. It
identifies the tools needed to implement the Strategy, of which many are already under development,
tried and tested. UNITAID remains creative in its approach, and is ready and able to develop new tools or engage in new partnerships that will ensure its objectives are met. UNITAID’s innovative source of income will continue to be well invested, and UNITAID will strive to increase its funding capacity through new and existing donors.